Methods for enhancing antibody-induced cell lysis and treating cancer

Details for Australian Patent Application No. 2009212978 (hide)

Owner Coley Pharmaceutical GmbH University of Iowa Research Foundation

Inventors Hartmann, Gunther; Weiner, George

Agent Davies Collison Cave

Pub. Number AU-A-2009212978

Priority 60/213,346 22.06.00 US

Filing date 1 September 2009

Wipo publication date 1 October 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61P 35/02 (2006.01) Antineoplastic agents

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

1 October 2009 Application Open to Public Inspection

  Published as AU-A-2009212978

1 October 2009 Complete Application Filed

  Priority application(s): 60/213,346 22.06.00 US

25 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009212979-Psychotherapeutic device

2009212977-Electric powertrain for off-highway trucks